MAD2L1BP Antikörper (AA 1-274)
-
- Target Alle MAD2L1BP Antikörper anzeigen
- MAD2L1BP (MAD2L1 Binding Protein (MAD2L1BP))
-
Bindungsspezifität
- AA 1-274
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAD2L1BP Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human MAD2L1BP
- Homologie
- Percent identity by BLAST analysis: Human (100%) Bovine (87%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Recombinant fragment corresponding to a region within amino acids 1 and 274 of MAD2L1 binding protein (SwissProt Q15013). Percent identity by BLAST analysis: Human (100%), Bovine (87%).
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product MAD2L1BP Primärantikörper
-
anti-MAD2L1 Binding Protein (MAD2L1BP) (AA 1-274) antibody
MAD2L1BP Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 4G11 unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) antibodyMAD2L1BP Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (AA 1-306) antibodyMAD2L1BP Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (AA 1-274) antibodyMAD2L1BP Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (AA 1-306) antibodyMAD2L1BP Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (N-Term) antibodyMAD2L1BP Reaktivität: Human WB, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) antibodyMAD2L1BP Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Monoclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (N-Term) antibodyMAD2L1BP Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-MAD2L1 Binding Protein (MAD2L1BP) (AA 171-274) antibodyMAD2L1BP Reaktivität: Human ELISA, IP Wirt: Maus Monoclonal 4B9 unconjugated
-
- Applikationshinweise
-
Approved: WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- 0.1 M Tris-glycine, pH 7, 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
- Target
- MAD2L1BP (MAD2L1 Binding Protein (MAD2L1BP))
- Andere Bezeichnung
- CMT2 / MAD2L1BP (MAD2L1BP Produkte)
- Synonyme
- MAD2L1BP antikoerper, CMT2 antikoerper, RP1-261G23.6 antikoerper, 0610009D16Rik antikoerper, 2510031P20Rik antikoerper, AU018945 antikoerper, AW550977 antikoerper, C76045 antikoerper, CMT2A antikoerper, CMT2B antikoerper, Mad2lbp antikoerper, mKIAA0110 antikoerper, MAD2L1 binding protein antikoerper, Mad2l1bp antikoerper, MAD2L1BP antikoerper
- Hintergrund
-
Name/Gene ID: MAD2L1BP
Synonyms: MAD2L1BP, CMT2, DJ261G23.1, MAD2L1 binding protein, KIAA0110, RP1-261G23.6, MAD2L1-binding protein, Caught by MAD2 protein - Gen-ID
- 9587
- UniProt
- Q15013
-
